We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$254M
AUM Growth
+$14.3M
Cap. Flow
+$11.4M
Cap. Flow %
4.51%
Top 10 Hldgs %
51.18%
Holding
152
New
3
Increased
33
Reduced
31
Closed
10

Top Buys

Rank Stock Value
1
VYMI icon
Vanguard International High Dividend Yield ETF
VYMI
+$6.16M
2
FDN icon
First Trust Dow Jones Internet Index Fund ETF
FDN
+$3.5M
3
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$1.59M
4
ETP
Energy Transfer Partners L.p.
ETP
+$1.38M
5
SLY
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
+$1.1M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.18M
2
XOM icon
ExxonMobil
XOM
+$1.1M
3
VNQ icon
Vanguard Real Estate ETF
VNQ
+$883K
4
KMI icon
Kinder Morgan
KMI
+$674K
5
IFF icon
International Flavors & Fragrances
IFF
+$515K

Sector Composition

Rank Sector Weight
1 Healthcare 25.84%
2 Energy 8.13%
3 Financials 4.88%
4 Communication Services 4.83%
5 Technology 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
126
DELISTED
Immunogen Inc
IMGN
$244K 0.1%
34,315
– –
SJM icon
127
J.M. Smucker
SJM
$12.8B
$237K 0.09%
2,000
– –
RSP icon
128
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$232K 0.09%
2,500
– –
APA icon
129
APA Corp
APA
$13.2B
$229K 0.09%
4,783
– –
MDT icon
130
Medtronic
MDT
$112B
$229K 0.09%
2,585
– –
DLB icon
131
Dolby
DLB
$5.79B
$214K 0.08%
4,369
– –
VZ icon
132
Verizon
VZ
$196B
$214K 0.08%
4,800
– –
ABBV icon
133
AbbVie
ABBV
$435B
$212K 0.08%
2,920
-200
-6% -$13.4K
IWM icon
134
iShares Russell 2000 ETF
IWM
$83B
$211K 0.08%
1,496
– –
IXN icon
135
iShares Global Tech ETF
IXN
$8.83B
$209K 0.08%
+9,564
New +$207K
PGX icon
136
Invesco Preferred ETF
PGX
$3.79B
$207K 0.08%
13,730
– –
ABT icon
137
Abbott
ABT
$187B
$206K 0.08%
+4,232
New +$192K
AMLP icon
138
Alerian MLP ETF
AMLP
$12.8B
$205K 0.08%
3,420
– –
TERP
139
DELISTED
TerraForm Power, Inc
TERP
$120K 0.05%
10,000
– –
BCRX icon
140
BioCryst Pharmaceuticals
BCRX
$2.4B
$111K 0.04%
20,000
– –
IRD
141
Opus Genetics
IRD
$302M
$43K 0.02%
313
– –
BMY icon
142
Bristol-Myers Squibb
BMY
$132B
– –
-4,152
Closed -$226K
DARE icon
143
Dare Bioscience
DARE
$21M
– –
-167
Closed -$16K
IBB icon
144
iShares Biotechnology ETF
IBB
$9.77B
– –
-2,100
Closed -$205K
PKW icon
145
Invesco BuyBack Achievers ETF
PKW
$1.76B
– –
-4,500
Closed -$233K
VDE icon
146
Vanguard Energy ETF
VDE
$9.74B
– –
-2,500
Closed -$241K
WFC icon
147
Wells Fargo
WFC
$264B
– –
-5,200
Closed -$289K
WFC.PRL icon
148
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
– –
-275
Closed -$340K
XLE icon
149
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
– –
-10,000
Closed -$349K
CDK
150
DELISTED
CDK Global, Inc.
CDK
– –
-3,113
Closed -$202K
3 4 5
6
7

Similar funds

MC
Martin Currie Edinburgh, United Kingdom $2.61B AUM 29.41% 1-Year Est. Return
WBA
Walgreens Boots Alliance Deerfield, Illinois $2.24B AUM 36.34% 1-Year Est. Return
MD
Money Design Tokyo, Japan $2.14B AUM 10.33% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
SVCF
Silicon Valley Community Foundation Mountain View, California $1.77B AUM 13% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
MME
Meag Munich Ergo Munich, Germany $3.54B AUM 20% 1-Year Est. Return

Northeast Financial Consultants's Q2 2017 Portfolio in Review

As of Q2 2017, Northeast Financial Consultants held 152 positions worth $254M, up 6% from $239M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Northeast Financial Consultants deployed $11.4M of net new capital in Q2 2017, opening 3 new positions and adding to 33 existing holdings. Its largest new stake was Alibaba: 1,800 shares worth $254K.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $2.18M trimmed.

  • Northeast Financial Consultants's largest Q2 2017 buy was Alibaba: 1,800 shares worth $254K.
  • Northeast Financial Consultants added most to Vanguard International High Dividend Yield ETF in Q2 2017, an estimated $6.16M increase.
  • Northeast Financial Consultants's biggest Q2 2017 reduction was Pfizer, cutting an estimated $2.18M.
  • Northeast Financial Consultants fully exited Energy Transfer Partners, L.P. in Q2 2017, selling an estimated $484K.
  • Northeast Financial Consultants's ten largest holdings make up 51% of its $254M portfolio in Q2 2017.
  • Northeast Financial Consultants opened 3 new positions and closed 10 in Q2 2017.
  • Northeast Financial Consultants's portfolio value rose 6% quarter-over-quarter to $254M.

Based on Northeast Financial Consultants's 13F filing for Q2 2017, filed 26 Jul 2017.